# Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety

> **NCT06208241** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Amir Oron** · enrollment: 18 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Allocetra-OTS

## Key facts

- **NCT ID:** NCT06208241
- **Lead sponsor:** Amir Oron
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-12
- **Primary completion:** 2026-09-25
- **Final completion:** 2026-12-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06208241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06208241, "Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06208241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*